Find out if Novo's GLP-1 patent expiring in Canada is a mistake or a calculated move. Did the firm lose exclusivity over a ...

Discover the new migraine medications, such as monoclonal antibodies and gepants, that are changing migraine treatment for ...

On the occasion of its deal with Cure51, find out about NVIDIA's biotech strategy as it gets more and more involved in the ...

Since the approval of Luxturna, there has been a wave of gene therapies advancing in clinical trials to treat genetic vision ...

France’s biotech sector continues to evolve, blending a strong academic foundation with a growing number of startups tackling diverse disease areas. While funding remains a significant hurdle, ...

Delve into what the new CRISPR tool, CAST, has to offer. CRISPR-associated transposases are already gaining traction in ...

The companies Pathos AI, Taysha Gene Therapies, and Abeona Therapeutics bagged the biggest biotech funding rounds overall in ...

We’re nearly halfway through 2025, and like clockwork, the American Society of Clinical Oncology (ASCO) annual summit took place from the 30th of May to the 3rd of June in Chicago this year. With ...

Discover how biotechs and big pharma are developing novel treatments for high cholesterol with a range of different targets.

In the heat of the COVID-19 crisis, a wave of vaccine companies stepped into the spotlight with unprecedented speed and visibility. Riding a surge of public and private funding, they raced to develop ...

For decades, non-small cell lung cancer (NSCLC) stood as one of the formidable challenges in oncology, often diagnosed late and treated with limited options. But now, it looks like the therapeutic ...

What if the key to a greener future wasn’t in high-tech gadgets or sweeping legislation, but in mushrooms, plant cells, and even food waste? As the world scrambles to combat climate change and reduce ...